Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease

Clinical trial NCT03656627 · TERMINATED

Trial details

NCT number: NCT03656627
Sponsor: Alliance Foundation Trials, LLC.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Diseases Non-small Cell Lung Cancer Rheumatoid Arthritis Psoriasis Giant Cell Arteritis Polymyalgia Rheumatica Systemic Lupus Erythematosus Crohn Disease Multiple Sclerosis Ulcerative Colitis

Start date: 2019-06-27
Primary completion: 2021-03-18
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.